ORG Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$186K Buy
2,348
+223
+10% +$17.5K 0.03% 345
2025
Q3
$170K Sell
2,125
-27
-1% -$2.3K 0.03% 366
2025
Q2
$199K Buy
2,152
+144
+7% +$13.1K 0.04% 325
2025
Q1
$201K Sell
2,008
-136
-6% -$12.2K 0.05% 280
2024
Q4
$196K Sell
2,144
-1
-0% -$95 0.03% 322
2024
Q3
$223K Sell
2,145
-4,277
-67% -$436K 0.04% 268
2024
Q2
$614K Buy
6,422
+5,364
+507% +$495K 0.08% 216
2024
Q1
$94.3K Sell
1,058
-3,095
-75% -$262K 0.18% 77
2023
Q4
$331K Sell
4,153
-2,049
-33% -$154K 0.06% 229
2023
Q3
$441K Sell
6,202
-5,736
-48% -$429K 0.13% 171
2023
Q2
$919K Buy
+11,938
New +$924K 0.15% 131

Other funds holding CL

ORG Partners's CL Position: Q4 2025 in Review

ORG Partners increased its Colgate-Palmolive (CL) stake by 10% in Q4 2025, buying an estimated $17.5K and bringing the position to 2,348 shares worth $186K. The position accounts for 0.03% of the portfolio, ranked #345.

ORG Partners first reported a position in CL in Q2 2023 and has held it in 11 quarters since. The position peaked at $919K in Q2 2023. 1,892 funds tracked by Wall St. Rank hold CL as of Q4 2025.

  • ORG Partners held 2,348 shares of Colgate-Palmolive worth $186K as of Q4 2025.
  • ORG Partners bought 223 Colgate-Palmolive shares in Q4 2025, an estimated $17.5K.
  • Colgate-Palmolive made up 0.03% of ORG Partners's portfolio in Q4 2025, its #345 holding.
  • ORG Partners first reported a position in Colgate-Palmolive in Q2 2023 and has held it in 11 quarters since.
  • ORG Partners's Colgate-Palmolive position peaked at $919K in Q2 2023.
  • 1,892 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.